102570の収益Y / Y
102570の収益Y / Yは何ですか。
102570の収益Y / Yは30.35%です。
収益Y / Yの定義は何ですか。
過去3年間の年間収益の伸びは、過去3年間で平均した1年間の収益成長率です。
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
OTCのセクタHealth Careにおける収益Y / Yの企業と比べる102570
102570は何をしますか。
Electromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. Its products include WellnessPro Plus, a bioelectronics therapy prescription device to relieve chronic and acute pain. Electromedical Technologies, Inc. is headquartered in Scottsdale, Arizona.
102570と類似の収益y / y
- Atul Autoの収益Y / Yは30.20%です。
- Brookfield Business Partners L.Pの収益Y / Yは30.20%です。
- Brookfield Business Partners LPの収益Y / Yは30.20%です。
- CSSC Offshore & Marine Engineering ()の収益Y / Yは30.23%です。
- Senseonics Incの収益Y / Yは30.25%です。
- Samsonite International S.Aの収益Y / Yは30.35%です。
- 102570の収益Y / Yは30.35%です。
- iShares Trust - iShares Russell 2000 ETFの収益Y / Yは30.37%です。
- Larsen & Toubro Infotechの収益Y / Yは30.38%です。
- Infrastructure and Alternatives Incの収益Y / Yは30.38%です。
- Ultramarine & Pigmentsの収益Y / Yは30.40%です。
- Jenburkt Pharmaceuticalsの収益Y / Yは30.40%です。
- Marshall Motor Plcの収益Y / Yは30.43%です。